- Home
- PRSO vs PRFX Comparison
PRSO vs PRFX Comparison
Compare PRSO & PRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRSO
- PRFX
- Stock Information
- Founded
- PRSO 2008
- PRFX 2007
- Country
- PRSO United States
- PRFX Israel
- Employees
- PRSO N/A
- PRFX N/A
- Industry
- PRSO Semiconductors
- PRFX Biotechnology: Pharmaceutical Preparations
- Sector
- PRSO Technology
- PRFX Health Care
- Exchange
- PRSO Nasdaq
- PRFX Nasdaq
- Market Cap
- PRSO 4.3M
- PRFX 3.6M
- IPO Year
- PRSO 2001
- PRFX 2020
- Fundamental
- Price
- PRSO $0.96
- PRFX $1.91
- Analyst Decision
- PRSO Strong Buy
- PRFX Hold
- Analyst Count
- PRSO 2
- PRFX 1
- Target Price
- PRSO $3.38
- PRFX N/A
- AVG Volume (30 Days)
- PRSO 196.1K
- PRFX 358.6K
- Earning Date
- PRSO 05-12-2025
- PRFX 06-13-2025
- Dividend Yield
- PRSO N/A
- PRFX N/A
- EPS Growth
- PRSO N/A
- PRFX N/A
- EPS
- PRSO N/A
- PRFX N/A
- Revenue
- PRSO $15,626,000.00
- PRFX N/A
- Revenue This Year
- PRSO $3.96
- PRFX N/A
- Revenue Next Year
- PRSO $36.80
- PRFX N/A
- P/E Ratio
- PRSO N/A
- PRFX N/A
- Revenue Growth
- PRSO 35.50
- PRFX N/A
- 52 Week Low
- PRSO $0.52
- PRFX $1.68
- 52 Week High
- PRSO $2.34
- PRFX $19.20
- Technical
- Relative Strength Index (RSI)
- PRSO 53.21
- PRFX 40.14
- Support Level
- PRSO $0.86
- PRFX $1.85
- Resistance Level
- PRSO $1.03
- PRFX $1.95
- Average True Range (ATR)
- PRSO 0.08
- PRFX 0.09
- MACD
- PRSO -0.00
- PRFX 0.01
- Stochastic Oscillator
- PRSO 44.60
- PRFX 5.26
About PRSO Peraso Inc.
Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz, to 300 GHz. Geographically the company generates revenue from the United States, Hong Kong, Taiwan, and the Rest of the World.
About PRFX PainReform Ltd.
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.